Co-Occurring Symptoms Contribute to Persistent Fatigue in Prostate Cancer.

CONCLUSIONS: Persistent fatigue at 1 year after EBRT in prostate cancer survivors is likely related to a cluster of symptoms elicited by chronic inflammation. Therapies that target each of these symptoms will likely reduce fatigue in this patient population. PMID: 30625479 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30625479?dopt=Abstract

Source: Oncology - January 9, 2019 Category: Cancer & Oncology Authors: Feng LR, Fuss T, Dickinson K, Ross A, Saligan LN Tags: Oncology Source Type: research